Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ARK Autonomous Technology & Robotics ETF (ARKQ) vs Centene Corp (CNC) Price & Performance

ARK Autonomous Technology & Robotics ETF
Centene Corp

Price performance

Price movement over the last 24 hours

Key statistics

ARK Autonomous Technology & Robotics ETF vs Centene Corp — how do they compare? ARK Autonomous Technology & Robotics ETF trades at $123.27, while Centene Corp trades at $67.45 (market cap $33.26B). The key difference: Centene Corp is trading nearer its 52-week high, ARK Autonomous Technology & Robotics ETF nearer its low. Which is the better fit depends on your goals.

ARKQCNC
Sector
Sector/ThematicHealth
52-Week High
$143.82$68.34
52-Week Low
$91.86$25.21
Market Cap
$33.26B
Enterprise Value
$25.89B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ARK Autonomous Technology & Robotics ETF

ARKQ trades at $123.99, down 0.57% with a bearish technical signal from moving averages. The ETF focuses on autonomous technology and robotics, benefiting from AI momentum with 57% gains since Q1 2026. Support levels cluster around $122-124 while resistance sits at $126-128. Recent news highlights China's EV targets and humanoid robotics growth projections reaching $200 billion by 2035.

The ETF shows strong momentum in AI and robotics themes but carries premium valuations with a 36x P/E ratio. Key risks include sector concentration and dependency on technological adoption rates. Institutional interest remains strong with $2.7 billion in assets, though technical indicators suggest near-term consolidation pressure.

Centene Corp

Centene (CNC) trades at $67.35, down 0.37% on the day, with a bullish technical signal from moving averages. The stock shows attractive valuation ratios, including a P/E of 8.06 and P/S of 0.17, but faces profitability challenges with a negative net income margin of -3.25% for 2025. Recent positive developments include the renewal of a key Illinois Medicaid contract and consistent earnings beats in recent quarters, supporting a strong analyst consensus with 61% buy ratings.

The outlook for CNC hinges on successful margin recovery initiatives and cost management. Investment opportunities lie in its undervalued metrics and stable revenue base, but risks include persistent negative profitability, regulatory pressures in healthcare, and execution challenges in improving medical cost controls. The consensus price target of $63.36 suggests limited near-term upside from current levels.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ARK Autonomous Technology & Robotics ETF

ARKQ is an actively managed ETF that invests in autonomous technology and robotics. It focuses on disruptive innovations like autonomous mobility, electric vehicles, 3D printing, and energy storage, with holdings such as Tesla and Teradyne.

Read more on ARKQ

About Centene Corp

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.

Read more on CNC